Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04496518 · ClinicalTrials.gov registry record

Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)

A clinical trial of Ventricular Tachycardia, sponsored by Medtronic.

Active
Registry status
2,200
Enrollment target
20
Study locations

NCT04496518 is a study of Ventricular Tachycardia that is active but no longer recruiting, run by Medtronic. The registered enrollment target is 2,200 participants, above the 210-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (948% higher). The trial reports 20 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04496518, a study of Ventricular Tachycardia, is active but no longer recruiting, sponsored by Medtronic.

ACTIVE NOT RECRUITING
Registry status
2,200 participants
Enrollment target
20
Study locations

Study Summary

Medtronic is sponsoring the Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS) to further confirm safety and effectiveness of ventricular iATP therapy in routine clinical practice, following commercial release of iATP-capable devices. The iATP PAS is conducted within Medtronic's Product Surveillance Registry platform (NCT01524276).

Conditions Studied

Ventricular Tachycardia

Interventions

  • DEVICE Intrinsic Antitachycardia Pacing (iATP) Therapy

Study Locations (20)

Florida

  • Heart Rhythm Solutions - Hollywood
  • Baptist Health - Jacksonville
  • Cardiovascular Institute of Northwest Florida - Panama City
  • Heart & Vascular Institute of Florida - Safety Harbor
  • Heart Rhythm Consultants P.A. (Sarasota Memorial Research) - Sarasota

California

  • Chula Vista Cardiac Center - Chula Vista
  • Cardiovascular Consultants Medical Group (Van Nuys CA) - Van Nuys
  • Cardiology Associates Medical Group - Ventura

Colorado

  • Colorado Springs Cardiology - Colorado Springs
  • Denver Heart - Denver
  • Colorado Heart and Vascular, PC - Lakewood

Connecticut

  • Hartford Hospital - Hartford
  • Yale New Haven Hospital - New Haven

Arizona

  • Southwest EP - Chandler

Arkansas

  • Saint Vincent Heart Clinic Arkansas - Little Rock

Indiana

  • Deaconess Specialty Physicians - Evansville

Iowa

  • Iowa Heart Center (West Des Moines IA) - Des Moines

Trial Details

FieldValue
Enrollment Target 2,200 participants
Start Date 2020-08-01
Est. Completion 2028-01-31

Sponsor

Medtronic

30 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04496518

The ClinicalTrials.gov registry entry for NCT04496518 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 2,200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 210-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (948% higher). The listed sponsor is Medtronic, which has 30 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ventricular Tachycardia appearing as the primary indexed condition, and to 1 intervention - of which Intrinsic Antitachycardia Pacing (iATP) Therapy is the first listed.

NCT04496518 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Florida, California, Colorado.

Frequently Asked Questions

What is clinical trial NCT04496518 about?

NCT04496518 is a clinical study titled "Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)". Medtronic is sponsoring the Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS) to further confirm safety and effectiveness of ventricular iATP therapy in routine clinical practice, following commercial release of iATP-capable devices. The iATP PAS is conducted within Medtronic's Produc...

What is the current status of trial NCT04496518?

This trial is currently active not recruiting. The enrollment target is 2,200 participants. The study started on 2020-08-01. Estimated completion is 2028-01-31.

What conditions does trial NCT04496518 study?

This clinical trial studies the following conditions: Ventricular Tachycardia.

What interventions are being tested in trial NCT04496518?

The interventions under investigation include: Intrinsic Antitachycardia Pacing (iATP) Therapy (DEVICE).

Who is sponsoring clinical trial NCT04496518?

This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04496518 being conducted?

This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Ventricular Tachycardia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Ventricular Tachycardia

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.